Table 1.
Variables | Number (%) or median (range) |
---|---|
Age (years) | 63 (36–85) |
Sex (female) | 95 (65.9%) |
TB (μmol/L) | 11.8 (4.7–261.6) |
ALT (IU/L) | 24 (6–842) |
AST (IU/L) | 25 (13–850) |
ALB (g/L) | 41.1 (26.4–52.4) |
CA19-9 (U/mL) | 22.2 (0.1–>1000) |
CA125 (U/mL) | 19.7 (2.1–1567.0) |
Extent of liver resection | |
Wedge resection | 18 (12.5%) |
Segment IVb and V resection | 84 (58.3%) |
Right hemihepatectomy | 34 (23.6%) |
Right trisegmentectomy | 8 (5.6%) |
Lymph node dissection | |
D1 | 92 (63.9%) |
D2 | 52 (36.1%) |
Extrahepatic bile duct resection | 76 (52.8%) |
Adjacent organs resection | 15 (10.4%) |
Portal vein reconstruction | 13 (9.0%) |
Hepatic artery reconstruction | 16 (11.1%) |
Estimated blood loss (mL) | 215 (50–800) |
Tumor stage | |
T2 | 62 (43.1%) |
T3 | 57 (39.6%) |
T4 | 25 (17.3%) |
LNs metastasis | 121 (84.0%) |
No. of positive LNs | 3 (0–13) |
No. of retrieved LNs | 8 (6–18) |
LNR | 0.33 (0–1) |
R0 resection | 119 (82.6%) |
Tumor differentiation | |
Poorly | 85 (59.0%) |
Well, moderately | 59 (41.0%) |
Perineural invasion | 33 (22.9%) |
Intravascular invasion | 29 (20.1%) |
Postoperative complications | 48 (33.3%) |
Postoperative hospital stay (days) | 7 (4–47) |
Postoperative chemotherapy | 32 (22.2%) |
TB, total bilirubin; ALT, alanine aminotransferase; AST, aspartate transaminase; ALB, albumin; LNs, lymph nodes; LNR, lymph node ratio